Froimson Mark — SEC insider filings
SEC reporting owner CIK 1709050. 12 insider filings on record with FilingPulse; latest filed 2026-11-17.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2021-03-17 to 2026-11-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 1,400 shares, $16,212 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 3 legs across 3 filings — 2,234 shares, $123,314 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 24.
- Largest priced transaction: sale of 1,000 shares @ $59.37 ($59,370) in Pacira BioSciences, Inc., filed 2022-05-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Pacira BioSciences, Inc. (PCRX) | Director | 12 | 1 leg · 1,400 sh · $16,212 | 3 legs · 2,234 sh · $123,314 | 24 |
Insider filings — Froimson Mark
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-17 | 4 | Pacira BioSciences, Inc. (PCRX) | Code (U): 20,136 @ $36.50 · Disposition to issuer (D): 6,405 @ $36.50 · Disposition to issuer (D): 4,693 (derivative) · Disposition to issuer (D): 8,437 (derivative) · Disposition to issuer (D): 8,027 (derivative) · Disposition to issuer (D): 7,626 (derivative) · +5 more | EDGAR |
| 2026-06-12 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 6,405 @ $0 · Grant/award (A): 10,891 (derivative) @ $0 | EDGAR |
| 2026-03-19 | 4 | Pacira BioSciences, Inc. (PCRX) | Sale (S): 500 @ $21.81 | EDGAR |
| 2025-06-13 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 6,163 @ $0 · Grant/award (A): 11,279 (derivative) @ $0 | EDGAR |
| 2024-08-12 | 4 | Pacira BioSciences, Inc. (PCRX) | Purchase (P): 1,400 @ $11.58 | EDGAR |
| 2024-06-13 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 5,230 @ $0 · Grant/award (A): 12,179 (derivative) @ $0 | EDGAR |
| 2023-06-16 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 1,775 @ $0 · Grant/award (A): 12,925 (derivative) @ $0 | EDGAR |
| 2022-06-08 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 1,160 @ $0 · Grant/award (A): 8,225 (derivative) @ $0 | EDGAR |
| 2022-05-11 | 4 | Pacira BioSciences, Inc. (PCRX) | Sale (S): 1,000 @ $59.37 | EDGAR |
| 2021-12-20 | 4 | Pacira BioSciences, Inc. (PCRX) | Gift (G): 400 @ $0 | EDGAR |
| 2021-06-11 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 1,066 @ $0 · Grant/award (A): 7,626 (derivative) @ $0 | EDGAR |
| 2021-03-17 | 4 | Pacira BioSciences, Inc. (PCRX) | Sale (S): 734 @ $72.26 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1709050 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs